Biblio Discovery — Demo Discovery Service

5 hasil untuk "Alexandre Perani"

Menampilkan 1–5 · 0,36 detik · RSS

  1. Artikel Jurnal

    Hereditary predisposition to malignant myeloid hemopathies: Caution in use of saliva and guideline based on our experience

    Alexandre Perani; Sylvie Bourthoumieu; David Rizzo dkk.

    Frontiers in Oncology, Vol. 13 · 2023 · Inggris · DOAJ Scopus

    BackgroundPredisposition to myeloid malignancies is a field at the border of hematology and genetics. Knowledge in this domain has so rapidly increased that WHO defined in 2016 the new “Myeloid Neoplasms with Germline Predisposition” category of tumors. High throughput sequencing is frequently…

  2. Artikel Jurnal

    New structural variations responsible for Charcot-Marie-Tooth disease: The first two large KIF5A deletions detected by CovCopCan software

    Ioanna Pyromali; Alexandre Perani; Angélique Nizou dkk.

    Computational and Structural Biotechnology Journal, Vol. 19 · 2021 · Inggris · DOAJ Scopus

    Next-generation sequencing (NGS) allows the detection of mutations in inherited genetic diseases, like the Charcot-Marie-Tooth disease (CMT) which is the most common hereditary peripheral neuropathy. The majority of mutations detected by NGS are single nucleotide variants (SNVs) or small indels…

  3. Artikel Jurnal

    Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital

    Sandra Pinet; Stéphanie Durand; Alexandre Perani dkk.

    Frontiers in Oncology, Vol. 13 · 2023 · Inggris · DOAJ Scopus

    BackgroundIn the context of personalized medicine, screening patients to identify targetable molecular alterations is essential for therapeutic decisions such as inclusion in clinical trials, early access to therapies, or compassionate treatment. The objective of this study was to determine the…

  4. Artikel Jurnal

    Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

    Michael Loschi; Marie-Charlotte Villy; Jacques-Emmanuel Galimard dkk.

    Blood Advances, Vol. 9 No. 24 · 2025 · Inggris · DOAJ Scopus

    Abstract: Germ line DDX41 mutations (DDX41mut) are identified in ∼5% of myeloid malignancies with an excess of blasts, representing a distinct myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) entity. The disease is associated with better outcomes than DDX41 wild-type (DDX41WT) cases, but…